Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 26,104 shares at $21.04 ($549K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $549k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.04 | 13,052 | $275K | 50.0% |
| 2 | $21.04 | 13,052 | $275K | 50.0% |
| Total | $21.04 avg | 26,104 | $549K | 100% |
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |